Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jian Zhang
Fudan University
Principal Investigator - Jiong Wu
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Cancer Hospital
Beijing, China
- Beijing Friendship Hospital
Beijing, China
- Beijing Luhe Hospital
Beijing, China
- Hunan Cancer Hospital
Changsha, China
- Fujian Cancer Hospital
Fuzhou, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, China
- Sun Yat-Sen University Cancer Prevention Center
Guangzhou, China
- Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
- the First Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
- the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
- Zhejiang Cancer Hospital
Hangzhou, China
- Affiliated Cancer Hospital of Harbin Medical University
Ha’erbin, China
- Anhui Provincal Hospital
Hefei, China
- Shandong Cancer Hospital
Jinan, China
- Linyi City Cancer Hospital
Linyi, China
- Linyi City People'S Hospital
Linyi, China
- the First Affiliated Hospital of Henan University of Science and Technology
Luoyang, China
- the Second Affiliated Hospital of Nanchang University
Nanchang, China
- Gulou Hospital Affiliated To Nanjing University School of Medicine
Nanjing, China
- Jiangsu Cancer Hospital
Nanjing, China
- Jiangsu Provincial People'S Hospital
Nanjing, China
- the First Affiliated Hospital of Nanjing Medical University/jiangsu Provincial People'S Hospital
Nanjing, China
- Affiliated Cancer Hospital of Guangxi Medical University
Nanning, China
- Nantong Cancer Hospital
Nantong, China
- Affiliated Hospital of Qingdao University
Qingdao, China
- Affiliated Cancer Hospital of Fudan University
Shanghai, China
- Changhai Hospital
Shanghai, China
- Fudan University Shanghai Cancer Center
Shanghai, China
- Shanghai East Hospital
Shanghai, China
- the Second Affiliated Hospital of Soochow University
Suzhou, China
- Union Hospital Affiliated To Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
- Zhongnan Hospital of Wuhan University
Wuhan, China
- Xuzhou Central Hospital
Xuzhou, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Mar 2023
- Primary completion
- 30 Jul 2026
- Completion
- 31 Dec 2026
- Last update posted
- 2 Feb 2026
- Registered enrollment
- 725
- Registry id
- NCT05744427
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.